Summary
This 2016 study characterises a regulatory pathway in which the microRNA miR-342-3p suppresses human lung cancer development by directly repressing E2F1, a transcription factor that drives MYC-dependent oncogenic programmes. The work contributes to mechanistic understanding of microRNA-mediated tumour suppression in non-small-cell lung cancer. Although conducted in cell culture, the findings suggest potential therapeutic targets for cancer intervention, though clinical translation remains uncertain.
UK applicability
The findings are relevant to UK cancer research and precision medicine initiatives, but represent fundamental science with unclear direct application to UK clinical practice or policy without further validation in animal models and clinical trials.
Key measures
miR-342-3p expression levels, E2F1 protein expression, MYC transcriptional activity, direct binding interactions between miR-342-3p and E2F1
Outcomes reported
The study investigated how the microRNA miR-342-3p regulates MYC transcriptional activity by directly targeting E2F1 in human lung cancer cells. The research appears to characterise the molecular mechanisms by which this microRNA suppresses oncogenic signalling pathways.
Topic tags
Dig deeper with Pulse AI.
Pulse AI has read the whole catalogue. Ask about this record, its theme, or how the findings apply to UK farming and policy — every answer cites the underlying studies.